Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
3.062
+0.002 (+0.08%)
Streaming Delayed Price
Updated: 9:33 AM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
10 Health Care Stocks Whale Activity In Today's Session
December 04, 2024
Via
Benzinga
S&P 500, Nasdaq Hit Record Highs To Start December
December 02, 2024
Stocks are a mixed bag this afternoon, with the S&P 500 Index and Nasdaq Composite earlier touching fresh record highs as the latter jumps triple digits.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
Via
Benzinga
Benzinga Bulls And Bears: Amazon, Tesla, Rivian, Palantir And How Dogecoin Helped Low-Income Families Achieve Homeownership
November 30, 2024
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Cassava Sciences
November 26, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Cassava Sciences
November 05, 2024
Via
Benzinga
How Is The Market Feeling About Cassava Sciences?
October 25, 2024
Via
Benzinga
This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
November 26, 2024
Via
Benzinga
Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 25, 2024
SAVA, ZM, KSS, RIVN, TSLA were among the trending stocks among investors on Monday Nov. 25, 2024.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 25, 2024
Via
Benzinga
Gold Down Over 3%; Rigetti Computing Shares Spike Higher
November 25, 2024
Via
Benzinga
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
November 25, 2024
Via
Benzinga
Topics
Economy
Exposures
Fossil Fuels
Interest Rates
$1000 Invested In This Stock 5 Years Ago Would Be Worth $20,000 Today
October 09, 2024
Via
Benzinga
Cassava Sciences Unusual Options Activity
September 27, 2024
Via
Benzinga
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
November 25, 2024
Pharma bro Martin Shkreli predicted Cassava Sciences stock would fall and the company would miss primary endpoints for its Phase 3 trial.
Via
Benzinga
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
November 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies
November 25, 2024
Cassava Sciences' stock fell after Phase 3 simufilam trial failed to meet key endpoints, prompting the discontinuation of its Alzheimer's studies.
Via
Benzinga
Cassava Sciences Plummets 85% After Embattled Alzheimer's Drug Flops
November 25, 2024
The company tested simufilam in patients with mild-to-moderate Alzheimer's disease.
Via
Investor's Business Daily
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
November 25, 2024
Via
Benzinga
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
November 08, 2024
GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on:
Via
Benzinga
Analysts Believe Cassava Sciences Now Has 300% Upside From Here
October 30, 2024
Cassava Sciences faces controversy over its Alzheimer's drug, simufilam, amid fraud allegations, yet analysts maintain a Buy rating with high upside potential.
Via
MarketBeat
Topics
Fraud
Lawsuit
Exposures
Criminal
Legal
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
Via
Benzinga
Crude Oil Falls Over 4%; US Trade Deficit Narrows In August
October 08, 2024
Via
Benzinga
Exposures
Fossil Fuels
What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday?
October 08, 2024
Cassava Sciences Inc. has agreed to a $40 million settlement over SEC charges related to misleading data for simufilam. The firm anticipates top-line results from the ReTHINK Phase 3 trial before...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
October 08, 2024
Via
Benzinga
This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
October 08, 2024
Via
Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
Bio-Path is advancing its obesity treatment BP1001-A and completing trials for BP1002 in acute myeloid leukemia, targeting resistance mechanisms in treatment. Preclinical studies for obesity are set...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Via
Benzinga
Why Cassava Sciences Stock Dived by Almost 11% Today
September 27, 2024
Without admitting wrongdoing, the company put a regulatory controversy to rest, but this was expensive.
Via
The Motley Fool
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.